Person

Nancy A. Grygiel

SVP & CCO, Amgen

Current S&P 500 boards
0
Current roles
1
Open-market buys
$0
Open-market sales
$5.5M

Current roles

From Section 16 filings (Forms 3, 4 and 5) in the last 13 months.

Past roles

“Last filing” is the latest Form 3/4/5 for that company, an upper bound on the end date.

None on record since 2016.

Sits alongside

People who currently share a board or management team with this person.

Open-market trades

Purchases and sales reported on Form 4 at S&P 500 companies.

DateCompanyTypeSharesPriceValue
Aug 6, 2026AMGNSale1,000$402.16$402K
Aug 6, 2026AMGNSale1,970$402.16$792K
May 4, 2026AMGNSale1,237$323.73$400K
Nov 20, 2025AMGNSale1,639$337.26$553K
Nov 20, 2025AMGNSale1,500$337.26$506K
Aug 20, 2025AMGNSale1,267$296.99$376K
Feb 5, 2025AMGNSale1,589$304.47$484K
May 3, 2024AMGNSale2,117$313.09$663K
Dec 4, 2023AMGNSale2,096$273.03$572K
Nov 8, 2022AMGNSale545$293.54$160K
May 11, 2021AMGNSale2,500$252.51$631K

SEC reporting-owner ID (CIK) 1816414 · all filings on EDGAR

Nancy A. Grygiel (AMGN) | USBoard